Fangzheng Securities released a research report saying that the traditional probiotic market is expanding steadily, commercialization of next-generation probiotics is being implemented at an accelerated pace, and the global probiotic market may be booming for a long time, and the overall scale is expected to exceed 300 billion US dollars after 2035. Considering that the downstream brand pattern is relatively scattered, the midstream bacterial powder and formulation production pattern is more concentrated, and the Chinese market is in a domestic replacement dividend period. Therefore, it is recommended to focus on leading domestic companies that have extensive resources for independent patented functional strains and have certain production capacity for bacterial powders and formulations.

Fangzheng Securities released a research report saying that the traditional probiotic market is expanding steadily, commercialization of next-generation probiotics is being implemented at an accelerated pace, and the global probiotic market may be booming for a long time, and the overall scale is expected to exceed 300 billion US dollars after 2035. Considering that the downstream brand pattern is relatively scattered, the midstream bacterial powder and formulation production pattern is more concentrated, and the Chinese market is in a domestic replacement dividend period. Therefore, it is recommended to focus on leading domestic companies that have extensive resources for independent patented functional strains and have certain production capacity for bacterial powders and formulations.